| T. Rowe Price Capital Appreciation | PRWCX | 38,66 | +0,13% | 35,63B | 22/11 | |
| T. Rowe Price Blue Chip Growth | TRBCX | 200,50 | -0,12% | 32,43B | 22/11 | |
| T. Rowe Price Capital Appreciation I | TRAIX | 38,70 | +0,16% | 29,42B | 22/11 | |
| T. Rowe Price Blue Chip Growth I | TBCIX | 201,81 | -0,12% | 29,76B | 22/11 | |
| T. Rowe Price Instl Large Cap Growth | TRLGX | 86,12 | -0,20% | 22,62B | 22/11 | |
| T. Rowe Price Growth Stock I | PRUFX | 111,54 | 0,00% | 15,82B | 22/11 | |
| T. Rowe Price Dividend Growth | PRDGX | 83,26 | +0,68% | 13,17B | 22/11 | |
| T. Rowe Price Mid-Cap Growth I | RPTIX | 113,98 | +0,96% | 13,55B | 22/11 | |
| T. Rowe Price Growth Stock | PRGFX | 111,08 | 0,00% | 12,69B | 22/11 | |
| T. Rowe Price Mid-Cap Growth | RPMGX | 113,61 | +0,95% | 12,6B | 22/11 | |
| T. Rowe Price Dividend Growth I | PDGIX | 83,23 | +0,68% | 11,54B | 22/11 | |
| T. Rowe Price Equity Index 500 I | PRUIX | 157,30 | +0,35% | 10,88B | 22/11 | |
| T. Rowe Price New Horizons I | PRJIX | 63,72 | +1,79% | 10,92B | 22/11 | |
| T. Rowe Price Health Sciences | PRHSX | 94,43 | +0,40% | 8,5B | 22/11 | |
| T. Rowe Price Equity Income | PRFDX | 39,36 | +0,67% | 8,6B | 22/11 | |
| T. Rowe Price Equity Income I | REIPX | 39,32 | +0,67% | 8,71B | 22/11 | |
| T. Rowe Price New Horizons | PRNHX | 63,28 | +1,80% | 8,75B | 22/11 | |
| T. Rowe Price New America Growth | PRWAX | 81,76 | +0,41% | 8,5B | 22/11 | |
| T. Rowe Price Equity Index 500 | PREIX | 157,27 | +0,35% | 8,34B | 22/11 | |
| T. Rowe Price Capital Opportunity | PRCOX | 59,40 | +0,27% | 6,92B | 22/11 | |